Skip to content
Screener

Opus Genetics IRD Asset turnover

Asset turnover at other companies

AbbVie logo
AbbVieABBV
0.5×+0.1×
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
0.3×+0.2×
Regenxbio logo
RegenxbioRGNX
0.4×+0.1×
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
0.2×—
Opko Health logo
Opko HealthOPK
0.3×0.0×
uniQure logo
uniQureQURE
0×0.0×

Other financials

Income statement

See full
Revenue$2.2M-50.6%
Operating income-$14.4M-44.7%
Net income-$65.5M-700%
EPS (diluted)-$0.75-213%

Balance sheet

See full
Cash & equivalents$60.0M+43.5%
Total debt$1.2M—
Total equity-$45.8M-1,004%
Total assets$66.8M+38.7%

Cash flow

See full
Operating cash flow-$12.7M-41.5%

Valuation

See full
Market cap$304.5M+381%
Enterprise value$245.74M+672%
P/S25.4×+21.3×

Profitability

See full
Operating margin-359.1%-68.9pp
Net margin-892.4%-12,322pp

Returns & leverage

See full
Return on equity-449.4%-2,573pp
Debt / equity0.1×—
Current ratio7.1×+5.2×

Where this comes from

Calculated from Opus Genetics’s reported figures.

total revenue/total assets=0.2×

Based on trailing twelve months.

The source filing: Opus Genetics’s 10-Q, filed May 12, 2026. Open the filing →

Filed
May 12, 2026, 4:03 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-034084

FAQ

What is Opus Genetics's asset turnover?
Opus Genetics (IRD) reported asset turnover of 0.2× in Q1 2026.
How has Opus Genetics's asset turnover changed year-over-year?
Opus Genetics's asset turnover decreased by 23.6% year-over-year, from 0.3× to 0.2×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Ask your AI about Opus Genetics's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude